A simple index of lipid overaccumulation is a good marker of liver steatosis

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Bedogni, Giorgio ^a,b   Kahn, Henry S ^c   Bellentani, Stefano ^d   Tiribelli, Claudio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d AUSL Modena   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HUMAN; LIFESTYLE MODIFICATION; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BODY MASS; COMPARATIVE STUDY; DISEASE COURSE; INCIDENCE; INTRAABDOMINAL FAT; ITALY; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; INCIDENCE; INTRA-ABDOMINAL FAT; ITALY; LIPIDS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77955828718     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-98     Document Type: Article

References (42)

1. Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009, 13:511-531. 10.1016/j.cld.2009.07.005, 19818302.
2. Bedogni G, Bellentani S. Fatty liver: how frequent is it and why?. Ann Hepatol 2004, 3:63-65.
3. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008, 28:339-350. 10.1055/s-0028-1091978, 18956290.
4. Everhart JE, Bemba KM. Fatty liver: think globally. Hepatology 2010, 51:1491-1493.
5. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010, 51:679-689. 10.1002/hep.23280, 20041406.
6. Loria P, Lonardo A, Targher G. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. Clin Sci (Lond) 2008, 115:1-12. 10.1042/CS20070311, 19016656.
7. Moscatiello S, Manini R, Marchesini G. Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis 2007, 17:63-70. 10.1016/j.numecd.2006.08.004, 17164082.
8. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191:235-240. 10.1016/j.atherosclerosis.2006.08.021, 16970951.
9. Bellentani S, Dalle Grave R, Suppini A, Marchesini G, . Fatty Liver Italian Network Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 2008, 47:746-754. 10.1002/hep.22009, 18098321, Fatty Liver Italian Network.
10. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, Gasbarrini A, Loguercio C, Lonardo A, Marchesini G, Marra F, Persico M, Prati D, Baroni GS, . The NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato (AISF) Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010, 42:272-282. 10.1016/j.dld.2010.01.021, 20171943, The NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato (AISF).
11. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52. 10.1002/hep.20734, 15895401.
12. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33. 10.1186/1471-230X-6-33, 1636651, 17081293.
13. Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B, . RISC Investigators Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49:1537-1544. 10.1002/hep.22845, 19291789, RISC Investigators.
14. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, . Study Group TD Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010, 10:56. 10.1186/1471-230X-10-56, 2898845, 20529259, Study Group TD.
15. Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005, 5:26. 10.1186/1471-2261-5-26, 1236917, 16150143.
16. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care 2006, 29:151-153. 10.2337/diacare.29.01.06.dc05-1805, 16373916.
17. Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring) 2009,
18. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006, 25:127-141. 10.1002/sim.2331, 16217841.
19. Bedogni G, Miglioli L, Masutti F, Castiglione A, Crocè LS, Tiribelli C, Bellentani S. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 2007, 46:1387-1391. 10.1002/hep.21827, 17685472.
20. Bedogni G, Miglioli L, Masutti F, Ferri S, Castiglione A, Lenzi M, Crocè LS, Granito A, Tiribelli C, Bellentani S. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol 2008, 103:2248-2253. 10.1111/j.1572-0241.2008.01948.x, 18637095.
21. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994, 20:1442-1449. 10.1002/hep.1840200611, 7982643.
22. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007, 102:2708-2715. 10.1111/j.1572-0241.2007.01526.x, 17894848.
23. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual 1988, Champaign, IL: Human Kinetics Books.
24. World Health Organization Measuring Obesity: Classification and Distribution of Anthropometric Data. Report on a WHO consultation on epidemiology of obesity. Warsaw 21-23 October 1987 1989, Copenhagen: World Health Organization Regional Office for Europe, World Health Organization.
25. Thompson FE, Byers T. Dietary assessment resource manual. J Nutr 1994, 124:2245S-2317S.
26. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences 1988, New York: McGraw-Hill.
27. Ananth CV, Kleinbaum DG. Regression models for ordinal responses: a review of methods and applications. Int J Epidemiol 1997, 26:1323-1333. 10.1093/ije/26.6.1323, 9447413.
28. Bender R, Grouven U. Ordinal logistic regression in medical research. J R Coll Physicians Lond 1997, 31:546-551.
29. Raftery AE. Bayesian model selection in social research. Sociol Methodol 1995, 25:111-163.
30. Long JS, Freese J. Regression models for categorical dependent variables using Stata 2006, College Station, Tex.: StataCorp LP.
31. Gu W, Pepe M. Measures to summarize and compare the predictive capacity of markers. Int J Biostat 2009, 5:27.
32. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults (NIH publication no. 00-4084) 2000, Bethesda: National Institutes of Health.
33. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, Horlick M, Kotler D, Laferrère B, Mayer L, Pi-Sunyer FX, Pierson RN. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003, 77:379-384.
34. Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, Kuk JL, Seidell JC, Snijder MB, Sørensen TI, Després JP. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?. Obes Rev 2008, 9:312-325. 10.1111/j.1467-789X.2007.00411.x, 17956544.
35. Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med 2009, 7:21. 2684116, 19409076.
36. Altman DG, Royston P. What do we mean by validating a prognostic model?. Stat Med 2000, 19:453-473. 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5, 10694730.
37. Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis 2009, 13:545-563. 10.1016/j.cld.2009.07.009, 19818304.
38. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 2008, 51:1947-1953. 10.1007/s00125-008-1135-4, 18762907.
39. Perseghin G. Viewpoints on the way to a consensus session: where does insulin resistance start? The liver. Diabetes Care 2009, 32(Suppl 2):S164-S167. 10.2337/dc09-S303, 19875545.
40. Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E, . Look AHEAD Adipose Research Group Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 2010, 59:627-633. 10.2337/db09-1239, 20028945, Look AHEAD Adipose Research Group.
41. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007, 293:E1663-E1669. 10.1152/ajpendo.00590.2006, 17911339.
42. Kahn HS, Cheng YJ. Longitudinal changes in BMI and in an index estimating excess lipids among white and black adults in the United States. Int J Obes (Lond) 2008, 32:136-143. 10.1038/sj.ijo.0803697, 17684512.